Together, these results support the hypothesis that MTA in the extracellular compartment of MTAP-null GBM cells can work in concert with known M2 macrophage-stimulating cytokines in altering tumor associated macrophages, and/or directly promoting the alternative activation of macrophages as a single agent. This evidence concerns the gene MTAP and glioblastoma.